Abstract
The title compound [systematic name: 1-[(1R,2R,3S,4R)-2,3-dihydroxy-4-methyltetrahydrofuranyl]-5-fluoropyrimidine-2,4(1H,3H)-dione], C9H11FN2O5, is a prodrug of 5-fluorouracil used as a cytostatic in cancer therapy. Its crystal structure was determined from laboratory X-ray powder diffraction data. The compound crystallises in the triclinic space group P1 with two molecules in the asymmetric unit. These symmetrically independent molecules differ in their hydrogen-bond patterns, the pseudorotational angles P of their furanosyl fragments as well as their N-glycosidic torsion angles χ.
Graphical Abstract
The crystal structure of 5′-deoxy-5-fluorouridine, 1-[(1R,2R,3S,4R)-2,3-dihydroxy-4-methyltetrahydrofuranyl]-5-fluoropyrimidine-2,4(1H,3H)-dione], C9H11FN2O5, a prodrug of 5-fluorouracil used as a cytostatic in cancer therapy, was determined from laboratory X-ray powder diffraction data. The compound crystallises in the triclinic space group P1 with two symmetrically independent molecules differing in their hydrogen-bond patterns, the pseudorotational angles P of their furanosyl fragments as well as their N-glycosidic torsion angles χ.
Similar content being viewed by others
References
Heidelberger C, Chandhuri NK, Dannenberg P, Moore D, Griesbach L, Duschinsky R, Schnitzer RJ, Pleven E, Scheiner J (1957) Nature (London) 179:663
Duschinsky R, Pleven E, Heidelberger C (1957) J Am Chem Soc 79:4559
Cook AF (1978) US Patent No. 4 071 680
Cook AF, Holman MJ, Kramer MJ, Trown PW (1979) J Med Chem 22:1330
Liekens S, Bronckaers A, Pérez-Pérez MJ, Balzarini J (2007) Biochem Pharmacol 74:1555
Miwa M, Ura M, Nishida M, Sawada N, Ishikawa T, Mori K, Shimma N, Umeda I, Ishitsuka H (1998) Eur J Cancer 34:1274
Bajetta E, Colleoni M, Bartolomeo MD, Buzzoni R, Bozzetti F, Doci R, Somma L, Cappuzzo F, Stampino CG, Guenzi A, Balant LP, Zilembo N, Leo AD (1995) J Clin Oncol 13:2613
Armstrong RD, Cadman E (1983) Cancer Res 43:2525
Allen FH (2002) Acta Cryst B58:380
Valente EJ, Trager WF, Jensen LH (1975) Acta Cryst B31:954
Nakajima M, Genda T, Suehira M, Satoh H, Miki A, Hori S, Sawada Y (2010) Cancer Chemother Pharmacol 66:969
Pan D, Zhang H, Zhang T, Duan X (2010) Chem Eng Sci 65:3762
Wan L, Cao D, Zeng J, Ziemba A, Pizzorno G (2010) Nucleoside Nucleotide Nucl 29:488
Rohlíček J, Hušák M, Gavenda A, Jegorov A, Kratochvil B, Fitch A (2009) Acta Cryst E65:1325
Stoe & Cie (2004) WINXPOW. Stoe & Cie GmbH, Darmstadt
O’Neil MJ (2006) The Merck index: an encyclopedia of chemicals, drugs, and biologicals, 14th edn. Merck & Co., Inc., Whitehouse Station, p 582
David WIF, Sivia DS (2001) J Appl Crystallogr 34:318
Boultif A, Louër D (1991) J Appl Crystallogr 24:987–993
Hofmann DWM (2002) Acta Cryst B58:489
Pawley GS (1981) J Appl Crystallogr 14:357
David WIF, Shankland K, van de Streek J, Pidcock E, Motherwell WDS, Cole JC (2006) J Appl Crystallogr 39:910
Soni SD, Srikrishnan T (2004) Nucleoside Nucleotide Nucl 23:1779
Macrae CF, Bruno IJ, Chisholm JA, Edgington PR, McCabe P, Pidcock E, Rodriguez-Monge L, Taylor R, van de Streek J, Wood PA (2008) J Appl Cryst 41:466–470
Coelho AA (2007) TOPAS academic user manual. Version 4.1. Coelho Software, Brisbane
Bruno IJ, Cole JC, Kessler M, Luo J, Motherwell WDS, Purkis LH, Smith BR, Taylor R, Cooper RI, Harris SE, Orpen AG (2004) J Chem Inf Comput Sci 44:2133
March A (1932) Z Krist 81:285
Dollase WA (1986) J Appl Crystallogr 19:267
Mayo SL, Olafson BD, Goddard WA III (1990) J Phys Chem 94:8897
Accelrys (2003) Cerius2, Version 4.9. Accelrys Ltd., Cambridge
Etter MC, MacDonald JC, Bernstein J (1990) Acta Cryst B46:256
Bernstein J, Davis RE, Shimoni L, Chang N-L (1995) Angew Chem Int Ed 34:1555
Bernstein J, Shimoni L, Davis RE, Chang N-L (1995) Angew Chem Int Ed 107:1689
Nakai Y, Yamamoto K, Terada K, Uchida T, Shimizu N, Nishigaki S (1982) Chem Pharm Bull 30:2629
Kemme AA, Bleidelis YY, Lidak MY, Zhuk RA (1983) Zh Org Khim 19:1537
Harris DR, Macintyre WM (1964) Biophys J 4:203
Jarmula A, Anulewicz R, Les A, Cyranski MK, Adamowicz L, Bretner M, Felczak K, Kulikowski T, Krygowski TM, Rode W (1998) Biochim Biophys Acta 1382:277
Hempel A, Camerman N, Grierson J, Mastropaolo D, Camerman A (1999) Acta Cryst C55:632
McAtee JJ, Schinazi RF, Liotta DC (1998) J Org Chem 63:2161
Everaert DH, Peeters OM, Blaton NM, De Ranter CJ, Van Aerschot A, Herdewijn P (1992) Acta Cryst C48:590
IUPAC-IUB Joint Commission on Biochemical Nomenclature (1983) Pure Appl Chem 55:1273
Altona C, Sundaralingam M (1972) J Am Chem Soc 94:8205
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bekö, S.L., Urmann, D. & Schmidt, M.U. 5′-Deoxy-5-Fluorouridine: Characterisation, Crystal Structure and Molecular Conformations Determined from X-Ray Powder Data. J Chem Crystallogr 42, 933–940 (2012). https://doi.org/10.1007/s10870-012-0339-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10870-012-0339-0